Bemarituzumab, CAS [[1952272-74-0]]

Produktübersicht

• Artikelname: Bemarituzumab, CAS [[1952272-74-0]]
• Artikelnummer: AMO-M21498
• Hersteller Artikelnummer: M21498
• Alternativnummer: AMO-M21498-100UG
• Hersteller: Abmole Bioscience
• Kategorie: Biochemikalien

Produktbeschreibung

Bemarituzumab (FPA144) is a first-in-class, humanized, afucosylated immunoglobulin G1 monoclonal antibody (mAb) directed against fibroblast growth factor receptor 2b (FGFR2b) with two mechanisms of action against FGFR2b-overexpressing tumors: inhibition of FGFR2b signaling and enhanced antibody-dependent cell-mediated cytotoxicity (ADCC).

Produkteigenschaften

• Reinheit: >99%
• CAS Nummer: [1952272-74-0]
• Target-Kategorie: FGFR